Evidence map›Paper›PMID 35111719›Full record

ArticleFrontiers in public health

Rising XDR-Typhoid Fever Cases in Pakistan: Are We Heading Back to the Pre-antibiotic Era?

Muhammad Hammad Butt, Aqsa Saleem, Syed Owais Javed, Irfan Ullah, Mujeeb Ur Rehman, Nayyer Islam, Muhammad Azam Tahir, Tangina Malik, Sara Hafeez, Shahzadi Misbah

Abstract read
In one paragraph

Article in Frontiers in public health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Prolonged fever in ESBL-producingRadiology case reports · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Longevity of immune response after a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  13. Review
  14. Article
  15. Exploring the Antimicrobial Resistance Profile ofAntibiotics (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Muhammad Hammad ButtFaculty of Pharmacy, University of Central Punjab, Lahore, Pakistan.
Aqsa SaleemDow University of Health Sciences, Karachi, Pakistan.
Syed Owais JavedDow University of Health Sciences, Karachi, Pakistan.
Irfan UllahKabir Medical College, Gandhara University, Peshawar, Pakistan.
Mujeeb Ur RehmanDepartment of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.
Nayyer IslamDepartment of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.
Muhammad Azam TahirKhaldunia college of Pharmacy, Lahore, Pakistan.
Tangina MalikUniversity of the Punjab, Lahore, Pakistan.
Sara HafeezDepartment of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan.
Shahzadi MisbahFaculty of Pharmacy, University of Central Punjab, Lahore, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Typhoid FeverAnti-Bacterial AgentsHumansPakistanAnti-Bacterial AgentsCOVID-19infectious diseaseoutbreakPakistantropical disease

Identifiers

PMID35111719
PMCPMC8801676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.